Walter, Dirk H; Krankenberg, Hans; Balzer, Jörn O; Kalka, Christoph; Baumgartner, Iris; Schlüter, Michael; Tonn, Torsten; Seeger, Florian; Dimmeler, Stefanie; Lindhoff-Last, Edelgard; Zeiher, Andreas M (2011). Intraarterial administration of bone marrow mononuclear cells in patients with critical limb ischemia: a randomized-start, placebo-controlled pilot trial (PROVASA). Circulation: Cardiovascular interventions, 4(1), pp. 26-37. Philadelphia, Pa.: Lippincott Williams & Wilkins 10.1161/CIRCINTERVENTIONS.110.958348
Full text not available from this repository.Critical limb ischemia due to peripheral arterial occlusive disease is associated with a severely increased morbidity and mortality. There is no effective pharmacological therapy available. Injection of autologous bone marrow-derived mononuclear cells (BM-MNC) is a promising therapeutic option in patients with critical limb ischemia, but double-blind, randomized trials are lacking.
Item Type: |
Journal Article (Original Article) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Angiology |
UniBE Contributor: |
Baumgartner, Iris |
ISSN: |
1941-7632 |
Publisher: |
Lippincott Williams & Wilkins |
Language: |
English |
Submitter: |
Factscience Import |
Date Deposited: |
04 Oct 2013 14:11 |
Last Modified: |
05 Dec 2022 14:01 |
Publisher DOI: |
10.1161/CIRCINTERVENTIONS.110.958348 |
PubMed ID: |
21205939 |
Web of Science ID: |
000287351700007 |
URI: |
https://boris.unibe.ch/id/eprint/2224 (FactScience: 204522) |
Actions (login required)
 |
Edit item |